Rheumatology
Conference Coverage
High iron levels predict greater fracture risk, more so in men
“Once patients have an iron overload of more than 1,000 mcg/L, we need to be doing regular checks for their BMD and figuring how to best minimize...
From the Journals
Lower BMI linked with better knee osteoarthritis outcomes
Losing weight helps prevent the onset and progression of knee osteoarthritis, researchers in Australia report.
Conference Coverage
New ESC guidelines for cutting CV risk in noncardiac surgery
The guidelines, which aim to reduce cardiovascular complications from noncardiac surgery, introduce new concepts and recommendations, compared...
From the Journals
Autoimmune diseases linked to spike in post-MI events
“People with rheumatic arthritis, when they have a heart attack, are less likely to get the standard kind of treatments and have worse outcomes...
Conference Coverage
Fish oil pills do not reduce fractures in healthy seniors: VITAL
The largest worldwide study to examine how fish oil supplements might reduce the risk of fractures did not find any benefit.
From the Journals
Possible sex differences found in response to first treatments for early RA
In a relatively rare, but rigorous, look at sex differences in response to RA treatments, researchers found that men had higher rates of remission...
Conference Coverage
Hip fractures likely to double by 2050 as population ages
Greater efforts “are needed to prevent hip fractures and improve the treatment gap and post-fracture care, especially in men and the oldest old...
Conference Coverage
Crystal bone algorithm predicts early fractures, uses ICD codes
This algorithm looks promising and would alert clinicians to often-missed patients with high fracture risk who need to be investigated for...
Conference Coverage
COX-2, TNF inhibitor combo appear to have limited role in reducing axSpA spinal damage progression
Despite no statistical significance, there was a strong numerical signal of reduction in spinal structural damage of adding in a selective COX-2...
Conference Coverage
Bimekizumab effective for axSpA with or without prior TNFi treatment
Data after 24 weeks of treatment with bimekizumab in patients with nonradiographic and radiographic axial spondyloarthritis show good responses in...
From the Journals
Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?
Patients with isolated axial psoriatic arthritis (PsA) were older at diagnosis, more likely to have psoriatic nail lesions, and less likely to...